Section Arrow
CRIS.NASDAQ
- Curis
Quotes are at least 15-min delayed:2024/05/15 00:58 EDT
Last
 15.69
+0.03 (+0.19%)
Day High 
16.8 
Prev. Close
15.66 
1-M High
16.99 
Volume 
28.12K 
Bid
14.77
Ask
16.9
Day Low
15.0072 
Open
15.73 
1-M Low
13.9914 
Market Cap 
92.30M 
Currency USD 
P/E -- 
%Yield
10-SMA 16.08 
20-SMA 15.5 
50-SMA 13.41 
52-W High 19.6 
52-W Low 3.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.96/-7.20
Enterprise Value
93.79M
Balance Sheet
Book Value Per Share
1.61
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.88M
Operating Revenue Per Share
1.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8628+0.0221+2.63%-- 
JAGXJaguar Health0.2749-0.0154-5.30%-- 
NVAXNovavax13.48+0.37+2.82%-- 
SCPXScorpius Holdings0.0768-0.1047-57.69%-- 
RXRXRecursion Pharmaceuticals10.05+0.57+6.01%-- 
Quotes are at least 15-min delayed:2024/05/15 00:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.